ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Lyterian Therapeutics
Lyterian Therapeutics is seeking a Scientist, Biology to support its protein degradation drug discovery platform through designing and executing cellular screening assays, contributing to target characterization, and collaborating with multidisciplinary teams.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
Founded
2022
Lyterian Therapeutics is a biotechnology company developing small‑molecule therapeutics that harness physiologically relevant protein homeostasis mechanisms to treat disease. The company focuses on targeted protein degradation and related approaches to selectively remove or modulate pathogenic proteins. Lyterian aims to translate these biological insights into novel medicines by combining discovery chemistry and cellular biology to advance candidates toward clinical development.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lyterian Therapeutics.
Lyterian Therapeutics didn’t post a salary, so this is our estimate from similar listings.
4% below the average for this role
Steven James, Accomplished CEO and Biotech Executive, Joins Board of Directors of Rondo Therapeutics
Jul 2, 2024
